{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T01:04:34Z","timestamp":1786323874477,"version":"build-2736575974"},"reference-count":47,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T00:00:00Z","timestamp":1732147200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>The aim of this study was to conduct a systematic review and meta-analysis of the incidence of inflammatory bowel disease-associated bronchiectasis (IBD-BE) and to explore the possible risk factors for IBD-BE, which could help to understand the pulmonary involvement in patients with IBD and to determine the global incidence of the disease.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We searched PubMed and EMBASE databases to identify information on the prevalence of IBD-BE among IBD patients in the published literature. Information was extracted on study design, country, year, IBD-BE testing method, IBD characteristics, number of IBD-BE cases and total number of IBD patients, and factors associated with IBD-BE. We conducted meta-analyses using random-effects or fixed-effects models to estimate the prevalence of IBD-BE among IBD patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Out of a total of 682 studies, we identified 16 studies that reported prevalence. These studies used a heterogeneous approach to identify IBD-BE. In these 16 studies, there were 92,191 patients with IBD, of whom 372 cases of IBD-BE were identified. The results of the meta-analysis showed that the overall prevalence of IBD-BE in IBD derived from the use of a random effects model was 5.0% (95% CI 2.0\u201312.0%). In contrast, the prevalence of IBD-BE in studies using high-resolution chest computed tomography (HRCT) imaging was 12% (95% CI 4\u201339%) using a random-effects model. When only retrospective studies with sample sizes greater than 100 (<jats:italic>n<\/jats:italic>\u2009=\u20096) were considered, the prevalence was 1% (95% CI 0\u20131%). However, when only retrospective studies with sample sizes less than 100 were included (<jats:italic>n<\/jats:italic>\u2009=\u20094), the prevalence was 29% (95% CI 6\u2013100%); in prospective studies (<jats:italic>n<\/jats:italic>\u2009=\u20096), the combined prevalence was 11% (95% CI 4\u201329%). we performed a subgroup analysis of the differences in the incidence of IBD-BE between the different studies, each of which we subgrouped by type of study, type of disease, duration of disease, and diagnostic modality, and the results showed no significance. Future studies should standardize methods to identify IBD-BE cases and investigate the natural history and clinical course given the relatively high prevalence among IBD.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>In this systematic review and meta-analysis, the prevalence of IBD-BE was 12% among studies with HRCT imaging, suggesting that bronchiectasis may be an underestimated common extraintestinal manifestation of IBD. Asymptomatic patients with IBD-BE may present with abnormalities on HRCT or pulmonary function tests. Future studies should standardize methods to identify IBD-BE cases and investigate the natural history and clinical course given the relatively high prevalence among IBD.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fmed.2024.1447716","type":"journal-article","created":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T04:37:01Z","timestamp":1732163821000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["Prevalence of bronchiectasis in inflammatory bowel disease: a systematic review and meta-analysis"],"prefix":"10.3389","volume":"11","author":[{"given":"Yu","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihui","family":"Qiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miaomiao","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianyi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuoyang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haicheng","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zimeng","family":"Ning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,11,21]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/s12664-011-0129-1","article-title":"Pulmonary manifestations in inflammatory bowel disease: a prospective study","volume":"30","author":"Desai","year":"2011","journal-title":"Indian J Gastroenterol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/S0889-8553(21)00215-6","article-title":"Extraintestinal considerations in inflammatory bowel disease","volume":"24","author":"Levine","year":"1995","journal-title":"Gastroenterol Clin N Am"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1093\/ecco-jcc\/jjv232","article-title":"Prevalence and characteristics of extra-intestinal manifestations in a large cohort of Greek patients with inflammatory bowel disease","volume":"10","author":"Karmiris","year":"2016","journal-title":"J Crohns Colitis"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1001\/archinte.1976.03630040056012","article-title":"Unexplained bronchopulmonary disease with inflammatory bowel disease","volume":"136","author":"Kraft","year":"1976","journal-title":"Arch Intern Med"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1038\/s41424-018-0054-z","article-title":"Co-occurrence of asthma and the inflammatory bowel diseases: a systematic review and Meta-analysis","volume":"9","author":"Kuenzig","year":"2018","journal-title":"Clin Transl Gastroenterol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1186\/s12890-019-0963-y","article-title":"Association between inflammatory bowel disease and chronic obstructive pulmonary disease: a systematic review and meta-analysis","volume":"19","author":"Labarca","year":"2019","journal-title":"BMC Pulm Med"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"5187","DOI":"10.1007\/s10620-022-07385-z","article-title":"Prevalence of pulmonary diseases in association with inflammatory bowel disease","volume":"67","author":"Pemmasani","year":"2022","journal-title":"Dig Dis Sci"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/978-1-4684-3369-2_7","article-title":"A common mucosal immunologic system involving the bronchus, breast and bowel","volume":"107","author":"Bienenstock","year":"1978","journal-title":"Adv Exp Med Biol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"e1057","DOI":"10.1097\/MEG.0000000000002197","article-title":"Vedolizumab-induced acute interstitial lung injury in a 39-year-old male with ulcerative colitis","volume":"33","author":"Rizos","year":"2021","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1183\/09031936.00.15104100","article-title":"Clinical and radiological characteristics of lung disease in inflammatory bowel disease","volume":"15","author":"Mahadeva","year":"2000","journal-title":"Eur Respir J"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1097\/00005382-199321000-00010","article-title":"Inflammatory airways disease in ulcerative colitis: CT and high-resolution CT features","volume":"8","author":"Garg","year":"1993","journal-title":"J Thorac Imaging"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1183\/09031936.00.15100500","article-title":"The lung in inflammatory bowel disease","volume":"15","author":"Camus","year":"2000","journal-title":"Eur Respir J"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1378\/chest.113.6.1723","article-title":"Large airway disease associated with inflammatory bowel disease","volume":"113","author":"Spira","year":"1998","journal-title":"Chest"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"4819","DOI":"10.3748\/wjg.v12.i30.4819","article-title":"Extraintestinal manifestations and complications in inflammatory bowel diseases","volume":"12","author":"Rothfuss","year":"2006","journal-title":"World J Gastroenterol"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1097\/MPG.0000000000003823","article-title":"Pulmonary involvement in paediatric patients with inflammatory bowel disease","volume":"76","author":"Kourti","year":"2023","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1097\/00004836-200310000-00006","article-title":"Pulmonary function tests and high-resolution CT in the detection of pulmonary involvement in inflammatory bowel disease","volume":"37","author":"Song\u00fcr","year":"2003","journal-title":"J Clin Gastroenterol"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"4952","DOI":"10.3748\/wjg.v16.i39.4952","article-title":"Pulmonary involvement in inflammatory bowel disease","volume":"16","author":"Yilmaz","year":"2010","journal-title":"World J Gastroenterol"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1111\/resp.13420_62","article-title":"Prevalence and clinical characteristics of airway diseases in patients with ulcerative colitis","volume":"23","author":"Moda","year":"2018","journal-title":"Respirology"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.acra.2017.10.010","article-title":"Chest high-resolution computed tomography findings in 601 patients with inflammatory bowel diseases","volume":"25","author":"Sato","year":"2018","journal-title":"Acad Radiol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"S-436","DOI":"10.1016\/S0016-5085(11)61789-7","article-title":"Bronchopulmonary manifestations in inflammatory bowel diseases: a retrospective study from the GETAID","volume":"140","author":"Barge","year":"2011","journal-title":"Gastroenterology"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1016\/j.rmed.2012.03.005","article-title":"Low prevalence of pulmonary involvement in children with inflammatory bowel disease","volume":"106","author":"Peradzy\u0144ska","year":"2012","journal-title":"Respir Med"},{"key":"ref22","first-page":"255","article-title":"Pulmonary function tests, high-resolution computed tomography findings and inflammatory bowel disease","volume":"69","author":"Tunc","year":"2006","journal-title":"Acta Gastroenterol Belg"},{"key":"ref23","first-page":"11","article-title":"Pulmonary manifestations in inflammatory bowel disease","volume":"197","author":"Grewal","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/j.resinv.2022.06.003","article-title":"Airway involvement in inflammatory bowel disease: inflammatory bowel disease patients have bronchial wall thickening","volume":"60","author":"Majima","year":"2022","journal-title":"Respir Investig"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1053\/j.gastro.2005.06.021","article-title":"The clustering of other chronic inflammatory diseases in inflammatory bowel disease: a population-based study","volume":"129","author":"Bernstein","year":"2005","journal-title":"Gastroenterology"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"249","DOI":"10.4103\/1817-1737.191877","article-title":"Alterations of pulmonary function in patients with inflammatory bowel diseases","volume":"11","author":"Ji","year":"2016","journal-title":"Ann Thorac Med"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1136\/gut.27.8.919","article-title":"Latent pulmonary involvement in Crohn's disease: biological, functional, bronchoalveolar lavage and scintigraphic studies","volume":"27","author":"Bonniere","year":"1986","journal-title":"Gut"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/nrgastro.2015.186","article-title":"Immunopathogenesis of IBD: current state of the art","volume":"13","author":"de Souza","year":"2016","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1136\/gut.2007.122143","article-title":"Disorders of a modern lifestyle: reconciling the epidemiology of inflammatory bowel diseases","volume":"57","author":"Bernstein","year":"2008","journal-title":"Gut"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1136\/gutjnl-2012-303661","article-title":"Geographical variability and environmental risk factors in inflammatory bowel disease","volume":"62","author":"Ng","year":"2013","journal-title":"Gut"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1080\/00365521.2018.1447597","article-title":"Immunopathogenesis of inflammatory bowel disease and mechanisms of biological therapies","volume":"53","author":"Ahluwalia","year":"2018","journal-title":"Scand J Gastroenterol"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"11","DOI":"10.5217\/ir.2015.13.1.11","article-title":"Intestinal permeability regulation by tight junction: implication on inflammatory bowel diseases","volume":"13","author":"Lee","year":"2015","journal-title":"Intest Res"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"3117","DOI":"10.3748\/wjg.v22.i11.3117","article-title":"Tight junctions in inflammatory bowel diseases and inflammatory bowel disease associated colorectal cancer","volume":"22","author":"Landy","year":"2016","journal-title":"World J Gastroenterol"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"765474","DOI":"10.3389\/fmed.2021.765474","article-title":"Treatment of inflammatory bowel disease: a comprehensive review","volume":"8","author":"Cai","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1053\/j.gastro.2011.02.045","article-title":"Conventional medical management of inflammatory bowel disease","volume":"140","author":"Burger","year":"2011","journal-title":"Gastroenterology"},{"key":"ref36","first-page":"233","article-title":"Anti-TNF therapy in inflammatory bowel diseases: a huge review","volume":"56","author":"Peyrin-Biroulet","year":"2010","journal-title":"Minerva Gastroenterol Dietol"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"103329","DOI":"10.1016\/j.ebiom.2021.103329","article-title":"Evaluation of anti-TNF therapeutic response in patients with inflammatory bowel disease: current and novel biomarkers","volume":"66","author":"Cui","year":"2021","journal-title":"EBioMedicine"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1136\/gutjnl-2011-300904","article-title":"New therapies for inflammatory bowel disease: from the bench to the bedside","volume":"61","author":"Danese","year":"2012","journal-title":"Gut"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1097\/MOG.0000000000000444","article-title":"Inflammatory bowel disease therapy: blockade of cytokines and cytokine signaling pathways","volume":"34","author":"Yamamoto-Furusho","year":"2018","journal-title":"Curr Opin Gastroenterol"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1097\/01.mog.0000163168.06081.7d","article-title":"Probiotics in inflammatory bowel disease: possible mechanisms of action","volume":"21","author":"Dotan","year":"2005","journal-title":"Curr Opin Gastroenterol"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S1734-1140(11)70575-8","article-title":"Treatment of inflammatory bowel disease (IBD)","volume":"63","author":"Pithadia","year":"2011","journal-title":"Pharmacol Rep"},{"key":"ref42","first-page":"S3","article-title":"Treatment of diarrhea in patients with inflammatory bowel disease: concepts and cautions","volume":"7","author":"Shah","year":"2007","journal-title":"Rev Gastroenterol Disord"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1097\/00005792-199372030-00003","article-title":"The lung in inflammatory bowel disease","volume":"72","author":"Camus","year":"1993","journal-title":"Medicine (Baltimore)"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1016\/j.chest.2022.05.037","article-title":"Incidence, characteristics, clinical course, and risk factors of ulcerative colitis-related lung diseases","volume":"162","author":"Moda","year":"2022","journal-title":"Chest"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1093\/ecco-jcc\/jjab024","article-title":"Subclinical pulmonary involvement in active IBD responds to biologic therapy","volume":"15","author":"Ellrichmann","year":"2021","journal-title":"J Crohns Colitis"},{"key":"ref46","first-page":"1714","article-title":"Pulmonary complications in patients with inflammatory bowel disease","volume":"46","author":"Kuzela","year":"1999","journal-title":"Hepato-Gastroenterology"},{"key":"ref47","first-page":"154","article-title":"Pulmonary function in patients with inflammatory bowel disease","volume":"73","author":"Eade","year":"1980","journal-title":"Am J Gastroenterol"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2024.1447716\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T04:37:07Z","timestamp":1732163827000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2024.1447716\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,21]]},"references-count":47,"alternative-id":["10.3389\/fmed.2024.1447716"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2024.1447716","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,21]]},"article-number":"1447716"}}